Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
OCU-410ST by Ocugen for Juvenile Macular Degeneration (Stargardt Disease): Likelihood of Approval
OCU-410ST is under clinical development by Ocugen and currently in Phase II for Juvenile Macular Degeneration (Stargardt Disease). According to...
Baluretgene parvec by Ocugen for Leber Congenital Amaurosis (LCA): Likelihood of Approval
Baluretgene parvec is under clinical development by Ocugen and currently in Phase III for Leber Congenital Amaurosis (LCA). According to...
Baluretgene parvec by Ocugen for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Baluretgene parvec is under clinical development by Ocugen and currently in Phase III for Retinitis Pigmentosa (Retinitis). According to GlobalData,...